News & Updates

Bempedoic acid beneficial for prevention of cardiac events in high-risk patients

The use of bempedoic acid in primary prevention appears to lower the incidence of major cardiovascular events for high-risk patients, as shown in the subgroup analysis of the CLEAR Outcomes* trial.

Hypertension tied to weakened ventilatory efficiency

Hypertensive individuals without a diagnosis of heart failure appear to have impaired ventilatory efficiency, which reflects an abnormal physiological response to exercise, according to a study.

Watermelon good for the heart

Eating watermelon appears to have cardiovascular benefits, with the results of a systematic review and meta-analysis showing that the fruit has potential antihypertensive effects.

Swarming microrobotic platform enables aneurysm embolization with high fifilling ratio

Dapagliflozin helps prevent heart failure events, cardiovascular death

Treatment with dapagliflozin leads to a reduction in the rate of total heart failure (HF) events and cardiovascular death, irrespective of patient characteristics such as ejection fraction (EF), according to data from the DELIVER* trial.

Early hysterectomy poses increased CVD risk

Undergoing early hysterectomy appears to put women at heightened risk of a composite of cardiovascular disease (CVD), especially stroke, as reported in a study.

Atrial fibrillation patients use same anticoagulant after bleeding event

A recent study has shown that the majority of patients with nonvalvular atrial fibrillation who have had a bleeding event resume anticoagulation therapy usually with the same drug class that they have been using.